Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2015 call → NOWe need to determine if management describes that successive engagements of the same kind are coming in at progressively larger size. Look for statements about deals, orders, contracts, projects, customers, sites, or programs being individually bigger, broader, or longer than before. Scan the transcript for relevant comments. Jack Sanders mentions i6 engagements, new business, etc. He says: "we have over 30 customer engagements today" and "i6 is generating tremendous interest." He also mentions "we already won some new business promise, it's kind of 3 million a year for me" - that seems like a small amount. He talks about TruVue container, ClearView, etc. He says "we've had three or four new contact from potential customers" - but that's just interest. He also says "The growth you see in flexibles is really an output of i6." But no mention of larger deal sizes. He mentions "we are adding a new triplex laminator and a new rotogravure press" - that's capacity, not deal size. He talks about "EvoCan" line, but no size comparison. He says "we have over 30 customer engagements" - but that's number of engagements, not size. He says "we already won some new business promise, it's kind of 3 million a year" - that seems small. He says "we've had three or four new contact from potential customers" - again, just interest. No mention of deals being larger than before. No comparison against past deal sizes. No statement that new orders are bigger. Also, he mentions "we are actively pursuing opportunities in flexibles" - but that's M&A, not deal size. Thus, no evidence of escalating unit size. Answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.